Glucocorticoid receptor mediated suppression of natural killer cell activity: Identification of associated deacetylase and corepressor molecules

Cellular Immunology

Volumn 275, Issue 1-2, 2012, Pages 80-89

  Bush, Kristin A ^a   Krukowski, Karen ^a   Eddy, Justin L ^a   Janusek, Linda Witek ^b   Mathews, Herbert L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Corepressor; Epigenetic; Glucocorticoid receptor; Histone deacetylase; Natural killer cell

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR;

ARTICLE; CELL STRAIN K 562; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; FLOW CYTOMETRY; GENE REPRESSION; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; STRESS; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CO-REPRESSOR PROTEINS; DEXAMETHASONE; HISTONE DEACETYLASES; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, GLUCOCORTICOID;

EID: 84860591996     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.02.014     Document Type: Article

References (48)

1. Witek-Janusek L., Mathews H.L. Stress, immunity, and health outcomes. Handbook of Stress, Coping, and Health: Implications for Nursing Research, Theory, and Practice 2000, 47-67. Thousand Oaks, Sage. E. Rice (Ed.).
2. Kemeny M.E., Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: A stepwise progression. Brain Behav. Immun. 2000, 21:1009-1018.
3. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: Implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
4. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
5. Schoneveld O., Cidlowski J.A. Glucocorticoids and immunity: Mechanisms of regulation. Psychoneuroimmunology 2007, 45-61. Elsevier Academic Press, Burlington, MA. R. Ader (Ed.).
6. Cippitelli M., Sica A., Viggiano V., Ye J., Ghosh P., Birrer M.J., Young H.A. Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 1995, 270:12548-12556.
7. Santourlidis S., Trompeter H.I., Weinhold S., Eisermann B., Meyer K.L., Wenert P., Uhrberg M. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 2002, 169:4253-4261.
8. Chan H.W., Miller J.S., Moore M.B., Lutz C.T. Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J. Immunol. 2005, 175:5966-5974.
9. Krukowski K., Eddy J., Konley T., Witek-Janusek L., Mathews H.L. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav. Immun. 2011, 25:239-249.
10. Freedman N.D., Yamamoto K.R. Importin 7 and importin α/importin β are nuclear import receptors for the glucocorticoid receptor. Mol. Biol. Cell. 2004, 15:2276-2286.
11. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458.
12. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleuking-1beta-induced histone H4 acetylation of lysines 8 and 12. Mol. Cell. Biol. 2000, 20:6891-6903.
13. Araki Y., Fann M., Wersto R., Weng N.P. Histone acetylation facilitates rapid and robust memory CD8T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J. Immunol. 2008, 180:8102-8108.
14. Lu Q., Wu A., Ray D., Deng C., Attwood J., Hanash S., Pipkin M., Lichtenheld M., Richardson B. DNA methylation and chromatin structure regulate T cell perforin gene expression. J. Immunol. 2003, 170:5124-5132.
15. Jones P.L., Sachs L.M., Rouse N., Wade P.A., Shi Y.B. Multiple N-CoR complexes contain distinct histone deacetylases. J. Biol. Chem. 2001, 276:8807-8811.
16. Yang W.M., Tsai S.C., Wen Y.D., Fejer G., Seto E. Functional domains of histone deacetylase-3. J. Biol. Chem. 2002, 277:9447-9454.
17. Li J., Wang J., Nawaz Z., Liu J.M., Qin J., Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000, 19:4342-4350.
18. Underhill C., Qutob M.S., Yee S.P., Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI-SNF complex and the corepressor KAP-1. J. Biol. Chem. 2000, 275:40463-40470.
19. Wen Y.D., Perissi V., Staszewski L.M., Yang W.M., Krones A., Glass C.K., Rosendfeld M.G., Seto E. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 2000, 97. 7207-7.
20. Jee Y.K., Gilmour J., Kelly A., Bowen H., Richards D., Soh C., Smith P., Hawrylowicz C., Cousins D., Lee T., Lavender P. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J. Biol. Chem. 2005, 280:23243-23250.
21. Waltregny D., Glenisson W., Tran S.L., North B.J., Verdin E., Colige A., Castronovo V. Histone deacetylases HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 2005, 19:966-968.
22. Longworth M.S., Laimins L.A. Histone deacetylase-3 localizes to the plasma membrane and is a substrate of Src. Oncogene 2006, 25:4495-4500.
23. Islam K.N., Mendelson C.R. Glucocorticoid/glucocorticoid receptor inhibition of surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive changes in histone modification at the SP-A promoter. Mol. Endocrinol. 2008, 22:585-596.
24. Barnes P.J. Anti-inflammatory mechanisms of glucocorticoids. Biochem. Soc. Trans. 1995, 23:940-945.
25. Limbourg F.P., Liao J.K. Nontranscriptional actions of the glucocorticoid receptor. J. Mol. Med. 2003, 81:168-174.
26. Holbrook N.J., Cox W.I., Horner H.C. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res. 1983, 43:4019-4025.
27. Zamir I., Harding H.P., Atkins G.B., Horlein A., Glass C.K., Rosenfeld M.G., Lazar M.A. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 1996, 16:5458-5465.
28. Drexler H.G., Matsuo Y. Malignant hematopoietic cell lines: In vitro models for the study of natural killer cell leukemia-lymphoma. Leukemia 2000, 14:777-782.
29. Qiu Y., Stavreva D.A., Luo Y., Indrawan A., Chang M., Hager G.L. Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter. J. Biol. Chem. 2011, 286:7641-7647.
30. Schmidt E.D., Janszen A.W., Wouterlood F.G., Tilders F.J. Interleukin-1-induced long-lasting changes in hypothalamic corticotrophin-releasing hormone (CRH) - neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J. Neurosci. 1995, 15:7417-7426.
31. Yeager M.P., Rassias A.J., Pioli P.A., Beach M.L., Wardwell K., Collins J.E., Lee H.K., Guyre P.M. Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin. Crit. Care Med. 2009, 37:2727-2732.
32. Witek-Janusek L., Gabram S., Mathews H.L. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Pyschoneuroendocrinol 2007, 32:22-35.
33. Beno D.W., Stover A.G., Mathews H.L. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J. Immunol. 1995, 154:5273-5281.
34. Yamamura Y., Rodriguez N., Schwartz A., Eylar E., Bagwell B., Yano N. A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell. Mol. Biol. 1995, 41:S121-S132.
35. Nagabhushan M., Mathews H.L., Witek-Janusek L. Aberrant nuclear expression of AP-1 NF-κB in lymphocytes of women stressed by the experience of breast biopsy. Brain Behav. Immun. 2001, 15:78-84.
36. Geng C.D., Vedeckis W.V. C-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J. Biol. Chem. 2005, 280:43264-43271.
37. Hong W., Baniahmad A., Li J., Chang C., Gao W., Liu Y. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors. FEBS Lett. 2009, 583:2451-2456.
38. Walther R.F., Lamprecht C., Ridsadale A., Groulx I., Lee S., Lefebvre Y.A., Hache R.J. Nuclear export of the glucocorticoid receptor is accelerated by cell fusion-dependent release of calreticulin. J. Biol. Chem. 2003, 278:10963-10971.
39. Carrigan A., Walther R.F., Salem H.A., Wu D., Atlas E., Lefebvre Y.A., Hache R.J. An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation. J. Biol. Chem. 2007, 282:37858-37864.
40. Sackey F.N., Hache R.J., Reich T., Kwast-Welfeld J., Lefebvre Y.A. Determinants of subcellular distribution of the glucocorticoid receptor. Mol. Endocrinol. 1996, 10:1191-1205.
41. Gatti G., Masera R., Cavallo R., Sartori M.L., Delponte D., Carignola R., Salvadori A., Angeli A. Studies on the mechanism of cortisol inhibition of human natural killer cell activity: Effects of calcium entry blockers and calmodulin antagonists. Steroids 1987, 49:601-616.
42. Savory J.G., His B., Laquian I.R., Giffin W., Reich T., Hache R.J., Lefebvre Y.A. Discrimination between NK1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol. Cell. Biol. 1999, 19:1025-1037.
43. Lu N.Z., Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 2005, 18:331-342.
44. Juan L.J., Shia W.J., Chen M.H., Yang W.M., Seto E., Lin Y.S., Wu C.W. Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 2000, 275:20436-20443.
45. Keedy K.S., Archin N.M., Gates A.T., Espeseth A., Hazuda D.J., Margolis D.M. A limited group of class I histone deacetylases act to repress human immunodeficiency virus type 1 expression. J. Virol. 2009, 83:4749-4756.
46. Dokmanovic M., Clarke C., Marks P.A. Histone deacetylase inhibitors: Overview and perspectives. Mol. Cancer Res. 2007, 5:981-989.
47. Yodio J., Teshigawara K., Nikaido T., Fukui K., Noma T., Honjo T., Takigawa M., Sasaki M., Minato N., Tsudo M. TCGF (IL2)-receptor inducing factor(s). I. Regulation of IL2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 1985, 134:1623-1630.
48. Montel A.H., Bochan M.R., Hobbs J.A., Lynch D.H., Brahmi Z. Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 1995, 166:236-246.